Biotech companies face the challenge of cutting costs to make their resources last through the economic downturn, while continuing to seek international patent protection for their inventions to ensure long-term viability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barrett, W. The patent gamble: strategic insights for playing the worldwide patent game. Nat Biotechnol 21, 1515–1517 (2003). https://doi.org/10.1038/nbt1203-1515
Issue Date:
DOI: https://doi.org/10.1038/nbt1203-1515